Arrhythmia Discrimination Using Multi-Vector IEGM Activation Times
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardioverter-defibrillators (ICDs) face challenges in accurately discriminating between ventricular tachyarrhythmias and supraventricular tachyarrhythmias, leading to inappropriate therapy delivery, particularly due to the overlap of ventricular rates and reliance on heart rate as the sole criterion, which can result in unnecessary shocks and suffering for patients.
Innovation Solution
The use of multiple sensing vectors to obtain intracardiac electrograms (IEGMs) from various ventricular regions, analyzing evoked response metrics and R-R interval stability to differentiate between arrhythmias, and adjusting pacing sites and patterns to match a predetermined preferred ventricular electrical activation sequence, enabling more precise arrhythmia characterization and therapy delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If heart rate is used as the sole criterion for arrhythmia discrimination, then the device complexity is reduced, but the measurement precision and reliability of arrhythmia discrimination deteriorate
Solution Approach 1:
The patent segments the arrhythmia discrimination task by analyzing multiple independent features (heart rate, R-R interval stability, activation times, morphology) rather than relying on a single criterion. This segmentation allows the system to maintain high measurement precision through multi-parameter analysis while managing complexity through modular feature evaluation.
Solution Approach 2:
The patent transitions from one-dimensional heart rate monitoring to multi-dimensional analysis by incorporating R-R interval stability, activation times, and waveform morphology. This dimensional expansion enables accurate discrimination between ventricular and supraventricular tachyarrhythmias even when heart rates overlap, resolving the contradiction between simplicity and precision.
2Measurement precision
If multiple sensing vectors and regional analysis are used to improve arrhythmia discrimination accuracy, then the measurement precision improves, but the device complexity and difficulty of detecting and measuring increase
Solution Approach 1:
The patent divides the ventricular chamber into multiple regions (first ventricular region, second ventricular region, third ventricular region) and analyzes evoked response metrics separately for each region. This segmentation enables precise local characterization of arrhythmias while managing measurement complexity through systematic regional evaluation.
Solution Approach 2:
The patent introduces evoked response metrics as intermediary parameters that mediate between the raw IEGM signals and the final arrhythmia discrimination. These metrics (such as R-R interval stability and activation times) simplify the complex signal processing into interpretable features that facilitate accurate discrimination without excessive computational burden.
3Reliability
If IEGMs from multiple ventricular regions are analyzed to characterize arrhythmias, then the reliability of arrhythmia discrimination improves, but the loss of information increases due to complex signal processing requirements
Solution Approach 1:
The patent extracts specific informative features (R-R interval stability, activation times, morphology characteristics) from the complex IEGM signals recorded from multiple ventricular regions. By selectively extracting these key features rather than processing the entire signal, the system maintains reliability through multi-regional analysis while minimizing information loss through feature-selective extraction.
Solution Approach 2:
The patent applies local quality analysis by examining evoked response metrics specific to each ventricular region (first, second, and third regions). This localized characterization preserves region-specific information and enables reliable arrhythmia discrimination while avoiding the information loss that would result from uniform processing of all regions.
4Productivity
If pacing therapy is adjusted to match predetermined preferred ventricular electrical activation sequence, then the productivity of cardiac function improves, but the device complexity increases
Solution Approach 1:
The patent implements feedback control by continuously monitoring actual ventricular activation sequences and comparing them against predetermined preferred patterns. Based on this feedback, the pacing system automatically adjusts pacing parameters to optimize cardiac function. This feedback mechanism improves productivity through adaptive pacing while managing complexity through automated control algorithms.
Data Source
AI summary
Described herein are implantable systems and devices, and methods for use therewith, that can be used to perform arrhythmia discrimination based on activation times. A plurality of different sensing vectors are used to obtain a plurality of IEGMs that collectively enable electrical activations to be detected in the left atrial (LA) chamber, the right atrial (RA) chamber, and at least one ventricular chamber of a patient's heart. For each of a plurality of cardiac cycles, there is a determination, based on the plurality of obtained IEGMs, of an LA activation time, an RA activation time, and a ventricular activation time. Arrhythmia discrimination is then performed based on the determined activation times.